Extraction of Oligonucleotides From Plasma Samples Across Multiple Species Using OligoWorks™ SPE Microplate Kit
This is an Application Brief and does not contain a detailed Experimental section.
Abstract
Oligonucleotide therapeutics are a key focus area for many drug developers today given their powerful ability to address disease biology at the level of gene transcription and translation with high target specificity and low toxicity. They are designed with specific types of modifications that enhance protein binding, half-life, and cellular uptake. Given their diversity, developing robust bioanalytical methods for oligonucleotide analysis can be quite challenging, and sample preparation is often its most challenging aspect due to the tight oligonucleotide-to-protein binding that occurs in biomatrices, often leading to low extraction recoveries and poor sensitivity. This work demonstrates use of the OligoWorks SPE Microplate Kit with RapiZyme™ Proteinase K Digestion to effectively extract oligonucleotides from plasma samples across multiple preclinical animal species including human. Using the starting protocol with no adjustments, oligonucleotide recoveries between 56–115% were obtained.
Experimental
Sample Preparation and Extraction
Figure 1. Graphical representation of the OligoWorks SPE Microplate Kit (p/n: 186010614) sample preparation protocol, with plasma sample digestion pretreatment using RapiZyme Proteinase K, followed by WAX SPE using the OligoWorks SPE microplate. LC-MS analysis of plasma sample extracts was performed with an ACQUITY™ UPLC™ I-Class PLUS (FL) coupled to a Waters Xevo™ TQ-XS Tandem Quadrupole Mass Spectrometer using multiple-reaction monitoring mode (MRM). Chromatographic separation was achieved ACQUITY UPLC Premier Oligonucleotide C18 Column, 130 Å, 1.7 µm, 2.1 x 50 mm (p/n: 186009484).Results
Ordering Information
720008499, September 2024